3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
A Delaware Court of Chancery granted FBB Holdings I's motions and enjoined Destination XL from terminating its merger agreement with FBB while the court makes further expedited determinations. The order is temporary and not a ruling on the merits, and DXL says it believes FBB's claims are without merit and will defend against them.
The Court of Chancery held a hearing on October 29, 2026 and granted both motions after it.
The merger agreement, dated December 11, 2025, allows either party to terminate if the merger is not completed by October 30, 2026.
FBB filed its complaint on October 26, 2026; DXL filed an answer and counterclaims on October 28, 2026.
DXL's preliminary proxy statement was filed July 17, 2026 and amended most recently on October 19, 2026.
Digital Brands Group received a notice of default on October 29, 2026 from the holder of its unsecured convertible note, which asserts the full note is immediately due at 120% of outstanding amounts. The holder says it will start legal proceedings unless it receives an acceptable extension proposal by the end of October 29, 2026, and the company disputes some of the assertions while evaluating its options.
Note principal is $3,529,412, issued July 23, 2026 under a Securities Purchase Agreement with Shakawe Capital LLC.
Holder cites a missed $1,000,000 partial payment due October 23, 2026 and a registration statement not filed by August 7, 2026.
Holder asserts the Mandatory Default Amount is 120% of outstanding principal, accrued interest and other amounts, with default interest of 20% per annum.
Company disputes certain assertions and says a material adverse effect on liquidity is possible if the note is accelerated or legal proceedings begin.
Ingersoll Rand's board approved an amended employment agreement with Chairman and CEO Vicente Reynal that extends his initial term to February 29, 2032, raises his base salary from $1.1 million to $1.2 million, and adds a performance-based equity award. The filing also reports that Senior Vice President Michael Weatherred retired effective immediately, and that Scott Watson and Shaun Carlson were promoted to group president roles. For shareholders, the new CEO award vests only if Adjusted EPS grows at a compound annual rate of at least 8% to 10% over five years.
Reynal's base salary rises from $1.1 million to $1.2 million; target bonus stays at 150% of base salary
Expected grant on November 23, 2026 of 226,098 performance stock units, valued at about $17.1 million, vesting on Adjusted EPS CAGR of 8% (50%) to 10% (100%) over 2027-2031
Michael Weatherred retired effective immediately after notice on October 27, 2026, and will serve in an advisory role through May 2028
Scott Watson and Shaun Carlson named senior vice presidents and group presidents, both internal promotions reporting to Reynal
Dauch Corporation preliminarily reported a third-quarter 2026 net loss attributable to Dauch of $42 million to $47 million and Adjusted EBITDA of $355 million to $360 million, ahead of full results due November 6, 2026. It lowered its full-year 2026 Adjusted EBITDA target to $1.350 billion to $1.375 billion from $1.360 billion to $1.425 billion, citing production volatility, rising inflation and higher energy costs, while raising its full-year sales target. The lower profit outlook matters to shareholders because it reduces expected earnings for the year.
Q3 2026 net loss attributable to Dauch expected at $42 million to $47 million; Adjusted EBITDA expected at $355 million to $360 million.
Full-year 2026 Adjusted EBITDA target cut to $1.350 billion to $1.375 billion from $1.360 billion to $1.425 billion.
Full-year 2026 sales target raised to $10.8 billion to $10.875 billion from $10.6 billion to $10.8 billion, including metal market pass-throughs.
Full third-quarter results and conference call scheduled for 10:00 a.m. ET on November 6, 2026.
Rapport Therapeutics closed an underwritten offering of common stock and pre-funded warrants and a $172.5 million offering of 2.25% convertible senior notes due 2032 on October 30, 2026. The company estimates net proceeds of about $215.7 million from the stock offering and $166.8 million from the notes, which it plans to use mainly to fund clinical trials of RAP-219, and it expects these funds plus existing cash to support operations through the end of 2029. Shareholders face dilution from the new shares and the potential conversion of the notes, and the company now carries a new debt obligation.
Stock offering: 8,333,334 firm shares at $21.00 each, plus 1,428,571 option shares exercised in full on October 28, 2026, and pre-funded warrants for up to 1,190,476 shares
Estimated net proceeds of $215.7 million from the stock offering and $166.8 million from the notes
$172.5 million of 2.25% convertible senior notes due December 1, 2032, with an initial conversion price of about $26.7750 per share
Notes offering closed October 30, 2026; the company says proceeds will fund operations through the end of 2029
Annovis Bio received a New York Stock Exchange notice on October 29, 2026, that it no longer meets continued listing standards because its 30-day average market capitalization and stockholders' equity were both below $50 million. The company has 9 months to regain compliance, and its common stock will keep trading under the symbol ANVS with a ".BC" designation while it works on a plan.
NYSE notice received October 29, 2026, under Section 802.01B of its Listed Company Manual
30-day average market capitalization was approximately $48.4 million as of October 28, 2026
Stockholders' deficit was approximately $(4.3) million as of June 30, 2026
Company must submit a compliance plan within 45 days of the notice; cure period is 9 months
Alset Inc. received a Nasdaq notice on October 28, 2026, because its closing bid price was below $1.00 for 30 consecutive trading days. The company has until April 26, 2027 to regain compliance, and the notice has no immediate effect on its listing, but failure to comply could lead to delisting proceedings.
Nasdaq notice dated October 28, 2026 cites a closing bid price below $1.00 for 30 consecutive trading days
Compliance deadline is April 26, 2027; regaining it requires a closing bid of at least $1.00 for 10 consecutive business days
The company previously announced a planned 1-for-5 reverse stock split and expects to announce its timing soon
TriCo Bancshares stockholders voted on October 29, 2026 to approve the merger agreement with First Hawaiian, Inc., under which TriCo will merge into First Hawaiian. First Hawaiian shareholders also approved the share issuance, and the companies expect the transaction to close later in 2026, subject to remaining closing conditions. The vote clears a key stockholder approval step but does not complete the deal.
Merger Proposal approved: 24,113,014 for, 223,343 against, 29,594 abstain
Non-binding Compensation Proposal approved: 22,950,706 for, 1,287,428 against, 127,816 abstain
Record date September 11, 2026; 31,966,630 shares outstanding; 24,365,951 shares present, constituting a quorum
Companies expect the transaction to close later in 2026, subject to remaining customary closing conditions
HF Sinclair agreed to repurchase 2,350,000 common shares from its largest holder, REH Advisors Inc., at $109.37 per share, or about $257 million in total, with completion expected on or around November 3, 2026. The filing says the REH Parties are expected to fall below the 5%-to-15% ownership range that gives them a right to designate a Board member, which could lead to that designee offering to resign by early 2027.
Shares: 2,350,000 common shares at $109.37 each, about $257 million total, funded with cash on hand
Expected completion: on or around November 3, 2026; shares will be held as treasury stock
Program status: $766 million repurchased to date under the $1.5 billion program authorized August 26, 2026, leaving about $734 million
Board: REH Designee must offer to resign within 30 days after January 13, 2027 if REH Parties remain below the 15% designation threshold
Utz Brands disclosed that CEO Howard Friedman will leave the company after the merger with Intersnack-linked buyers closes, with his employment expected to end November 30, 2026, and that he will leave the board at closing. The company also said board member B. John Lindeman received an offer to become CEO of Utz's post-closing operating company, subject to closing and a written employment agreement.
Friedman's employment is expected to end November 30, 2026, contingent on the merger closing; he leaves the board at closing
Friedman said his decision was not due to any disagreement with the company, Parent, or continuing stockholders
Lindeman received a letter agreement on October 29, 2026 offering the CEO role at Company LLC, with a contemplated start of November 30, 2026
Special meeting of stockholders is scheduled for November 13, 2026; two stockholder complaints were filed October 22, 2026, which the company says are without merit
Pioneer Bancorp reported third quarter 2026 net income of $85,000, or about $0.00 per share, down from $4.3 million, or $0.18 per share, a year earlier. The drop reflects a $6.2 million litigation-related expense tied to agreements in principle to resolve claims by Southwestern Payroll, Granite Solutions and NatPay, while net interest income rose 16.9% to $23.6 million.
Q3 2026 net income was $85,000 versus $4.3 million in Q3 2025; nine-month net income was $8.9 million, or $0.36 per diluted share, versus $16.5 million, or $0.67, a year earlier
Litigation-related expense of $6.2 million was recognized in the quarter; agreements in principle were reached in October 2026, subject to definitive settlement agreements
Net interest income rose $3.4 million, or 16.9%, to $23.6 million, and net interest margin was 4.26%, up 10 basis points
Noninterest expense rose 57.4% to $27.7 million; total deposits reached $2.13 billion, up 22.5% from December 31, 2025
Xcel Energy entered into a new equity distribution agreement on October 30, 2026, allowing it to sell up to $6.0 billion of common stock through sales agents, including forward sale arrangements. The filing also terminated its prior at-the-market program dated May 1, 2026, while forward sale agreements from earlier programs remain outstanding, so shareholders should note the potential for additional shares to be issued.
Up to $6.0 billion aggregate gross sales price of common stock (par value $2.50 per share) under the new Equity Distribution Agreement dated October 30, 2026
Prior at-the-market program dated May 1, 2026 was terminated; about $448.6 million of shares remained unsold at termination
About $3.8 billion of shares remain subject to outstanding forward sale agreements from the prior program, and about $2.2 billion from an August 1, 2025 agreement
Xcel Energy will not initially receive proceeds from borrowed shares sold under forward agreements; proceeds are expected on future physical settlement
FTI Consulting reported record third-quarter 2026 revenues of $1.013 billion, driven by growth across all five business segments, while net income declined due to a $46.0 million special charge for restructuring. The company reaffirmed its full-year 2026 revenue guidance between $3.940 billion and $4.100 billion while raising its adjusted EPS guidance range to between $9.50 and $10.00. Shareholders also saw share repurchases of 523,588 shares for $79.4 million during the quarter.
Q3 2026 revenues reached a record $1.013 billion, a 5.9% increase compared to $956.2 million in the prior year quarter.
Net income for the quarter was $63.4 million, down from $82.8 million in the prior year quarter, impacted by a $46.0 million special charge.
The company raised its full-year 2026 Adjusted EPS guidance range to between $9.50 and $10.00.
During the quarter, the company repurchased 523,588 shares of common stock at an average price of $151.55 per share for a total cost of $79.4 million.
Equity LifeStyle Properties said Patrick Waite will succeed Marguerite Nader as President and Chief executive officer effective January 1, 2027, and Waite will also join the Board. Nader will remain on the Board as Executive Vice Chair, and David Eldersveld will become Chief Operating Officer, as part of a multi-year succession plan. The filing reports no financial results or guidance changes.
Nader ceases to be Vice Chairman and CEO on December 31, 2026 and becomes Executive Vice Chair of the Board on January 1, 2027.
Waite, 60, becomes President and CEO on January 1, 2027 and is elected to the Board, which increases from nine to ten directors.
Waite's approved 2027 base salary is $614,935, with bonus potential of 290% of base salary; Eldersveld's is $476,558, with bonus potential of 220%.
The Board declared a fourth quarter 2026 dividend of $0.5425 per share, payable January 8, 2027 to holders of record on December 24, 2026.
Standex reported fiscal first-quarter 2027 sales of $232.6 million, up 7.0% from a year earlier, and GAAP diluted EPS of $1.99 versus $1.25. The company raised its fiscal 2027 outlook and authorized a new $100 million share repurchase program, which matters to shareholders because it signals higher expected earnings growth and a larger buyback capacity.
Net sales were $232.6 million, up 7.0% year over year; organic growth was 12.4%
Adjusted diluted EPS was $2.41, up 21.1% from $1.99; GAAP diluted EPS was $1.99 versus $1.25
Fiscal 2027 outlook raised to high-single-digit total sales growth, from mid-to-high single digits, with adjusted EPS now expected to grow high teens
Board authorized up to $100 million in share repurchases on October 27, 2026, replacing the approximately $23.5 million remaining under the prior authorization
Norwegian Cruise Line Holdings' subsidiary NCL Corporation signed two credit facility agreements on October 27, 2026, providing up to approximately $2.5 billion for each of two new cruise vessels, for total borrowing capacity of about $5 billion. The loans are backed by Italian state export credit agency SACE, which insures 100% of the loans subject to conditions, and the filing does not report any effect on the company's earnings or results.
Two facilities signed October 27, 2026, each up to approximately $2.5 billion, for Vessel 1 (delivery 2034) and Vessel 2 (delivery 2036)
Floating rate of six-month Term SOFR plus a 0.90% margin, with customary agency, structuring and commitment fees
Loans repaid in twenty-four equal semi-annual installments beginning six months after each ship's delivery; guaranteed by NCL Corporation
Facilities fund 80% of delivery payments under the shipbuilding contracts and are insured by SACE, subject to conditions
Bridger Aerospace received a Nasdaq deficiency letter on October 28, 2026, because its common stock closed below $1.00 per share for 30 consecutive business days ended October 27, 2026. The letter has no immediate effect, and the stock continues to trade on The Nasdaq Global Market as BAER, but the company must regain compliance or face possible delisting.
Nasdaq letter dated October 28, 2026 cites a minimum bid price of $1.00 per share under Listing Rule 5450(a)(1)
Compliance period runs until April 26, 2027
Regaining compliance requires a closing bid of at least $1.00 for ten consecutive business days, unless Nasdaq extends that period
The company may consider a reverse stock split if necessary; it cannot assure it will regain compliance
DoubleVerify reported third-quarter 2026 revenue of $205.6 million, up 9% from a year earlier, and net income of $15.9 million, up from $10.2 million. The company withdrew all previously issued financial outlook and guidance and suspended earnings calls while its pending merger is outstanding, which limits the forward information available to shareholders.
Q3 2026 revenue was $205.6 million, up 9%; activation revenue rose 10% to $117.6 million and measurement revenue rose 8% to $69.1 million.
Net income was $15.9 million, or $0.10 diluted EPS, versus $10.2 million, or $0.06, in Q3 2025; adjusted EBITDA was $75.4 million, a 37% margin.
Stockholders approved the Merger Agreement with Neptune BidCo US Inc. on October 29, 2026, with about 94% of votes cast in favor; the companies expect the deal to close by the first quarter of 2027.
All previously issued financial outlook and guidance were withdrawn, and future earnings calls were suspended for the duration of the pending transactions.
Nasdaq's Listing Qualifications Department issued a Staff Delisting Determination because the company's bid price stayed below $1.00 for 30 consecutive business days, and it is not eligible for a compliance period after its cumulative reverse stock splits totaled 1-for-2,000. The company intends to request a hearing before a Nasdaq Panel, which would stay the suspension; otherwise trading is scheduled to be suspended on November 5, 2026. Shareholders also approved raising authorized shares to 850,000,000, with the amendment effective October 30, 2026.
Nasdaq letter dated October 27, 2026 cites a closing bid price below $1.00 from September 15 through October 26, 2026.
Company is not eligible for a 180-day compliance period after 1-for-10 (July 8, 2025), 1-for-20 (May 8, 2026) and 1-for-10 (October 27, 2026) reverse splits.
Hearing request and $20,000 fee must reach Nasdaq by 4:00 p.m. Eastern Time on November 3, 2026, or trading is suspended at the opening on November 5, 2026.
Shareholders approved increasing authorized shares from 350,000,000 to 850,000,000; the proposal received 2,221,561 votes for and 53,946 against.
Peoples Bancorp Inc. completed its acquisition of Citizens National Corporation effective at the close of business on October 30, 2026, following a merger agreement first announced on April 21, 2026. Citizens had approximately $646 million in total assets at September 30, 2026, and its shareholders received 2.10 shares of Peoples common stock plus $8.00 in cash for each Citizens share.
Citizens had about $646 million in total assets, $344 million in total loans and $551 million in total deposits at September 30, 2026.
Each Citizens common share was exchanged for 2.10 Peoples common shares plus $8.00 in cash.
Citizens' 12 branches will operate initially as a division of Peoples Bank and convert to Peoples Bank branches after the close of business on April 19, 2027.
Actuate Therapeutics received a Nasdaq notice on October 28, 2026, stating its stock closed below the $1.00 minimum bid price for 30 consecutive business days. The company has until April 26, 2027 to regain compliance, and the stock continues to trade on The Nasdaq Global Market as ACTU for now. If it does not regain compliance, the stock could become subject to delisting, which matters to shareholders.
Nasdaq notice received October 28, 2026 under Listing Rule 5450(a)(1)
Compliance deadline is April 26, 2027; stock must close at or above $1.00 for at least 10 consecutive business days
Separate July 15, 2026 notice on minimum market value of listed securities; regain compliance by January 11, 2027
A second 180-day period may be available if the company moves its listing to the Nasdaq Capital Market
Neumora Therapeutics received a Nasdaq notice on October 26, 2026 that its common stock is below the $1.00 minimum bid price required for continued listing on the Nasdaq Global Select Market. The company has 180 calendar days, until April 26, 2027, to regain compliance, and the filing states there can be no assurance it will do so, which raises the risk of future delisting for shareholders.
Nasdaq notice received October 26, 2026 under Listing Rule 5450(a)(1) for the $1.00 minimum bid price
Compliance period runs 180 calendar days, until April 26, 2027
Regaining compliance requires a closing bid of at least $1.00 per share for ten consecutive business days
If not compliant, the company may need to apply to transfer to The Nasdaq Capital Market and may consider a reverse stock split
Verra Mobility said CFO Craig Conti will resign effective November 4, 2026. The Board appointed Matthew Kvarda, a Managing Director at Alvarez & Marsal, as interim CFO effective November 5, 2026, while a search firm assists in finding a permanent CFO. Kvarda's services are provided through an engagement with Alvarez & Marsal, which the company pays directly, and he will not receive compensation from Verra Mobility.
Craig Conti resigns as Executive Vice President and Chief Financial Officer effective November 4, 2026.
Matthew Kvarda, 56, is appointed interim CFO and principal financial officer effective November 5, 2026, until a permanent CFO is appointed.
Verra Mobility will pay Alvarez & Marsal $150,000 per month plus expenses, rising to $165,000 from May 1, 2027; fees through October 31, 2027 may not exceed $1,890,000 without consent.
Spencer Stuart is assisting the Board in the search for a permanent Chief Financial Officer.
Tempest Therapeutics said Chief Financial Officer Constance Ames resigned effective immediately on October 26, 2026, citing personal considerations unrelated to the company. The board appointed Stephanie Horn-Warnock as CFO, principal financial and accounting officer, treasurer and corporate secretary, also effective immediately, and she will work for the company as a consultant under an engagement letter dated October 28, 2026.
Constance Ames resigned as CFO and from all other company positions, effective immediately, for personal considerations unrelated to the company.
Stephanie Horn-Warnock, 37, was appointed CFO effective immediately on October 26, 2026.
Horn-Warnock previously was Vice President of Finance at ROM Technologies Inc. from January 2024 to September 2026.
Under her consulting engagement letter dated October 28, 2026, the company will pay $450 per hour plus expenses and an indirect cost allocation of 5.0% of total professional fees.
System1, Inc. said its President and Chief Operating Officer, Charles Ursini, resigned effective at the close of business on October 30, 2026. He will stay on the Board of Directors and serve as a strategic advisor to management, and the filing gives no replacement or financial details.
Charles Ursini resigned as President and Chief Operating Officer, effective close of business October 30, 2026
Ursini notified the company of the resignation on October 26, 2026
He had served as President and COO since April 2024
He will continue as a director and strategic advisor to management
On October 29, 2026, Texas Community Bancshares (TCBS) entered into a merger agreement to acquire The Banc of San Jacinto County Bancshares, the holding company for The Bank of San Jacinto County in Coldspring, Texas, for aggregate cash consideration of $9.5 million, funded with cash on hand and not subject to a financing condition. The target bank had total assets of $41.951 million as of June 30, 2026, and the merger is expected to close in the first quarter of 2027, subject to shareholder and regulatory approvals.
Merger Agreement signed October 29, 2026; SJCB merges into TCBS, and its bank merges into Broadstreet Bank, SSB
Aggregate cash consideration of $9.5 million, with TCBS expecting to fund it from cash on hand
SJCB Bank reported total loans of $12.515 million and total deposits of $35.305 million as of June 30, 2026
Closing expected in Q1 2027; requires approval by holders of two-thirds of SJCB shares and regulatory approvals; SJCB owes a $550,000 termination fee in specified cases
Bank of the James Financial Group reported third-quarter 2026 net income of $3.32 million, or $0.73 per share, up from $0.61 a year earlier, and nine-month net income of $9.34 million, or $2.05 per share. The board also raised the quarterly cash dividend 50% to $0.15 per share from $0.10, payable December 4, 2026 to holders of record on November 20, 2026.
Q3 2026 net income $3.32 million ($0.73 per share) vs. $2.75 million ($0.61) in Q3 2025
Nine-month net income $9.34 million ($2.05 per share) vs. $6.30 million ($1.39) a year earlier
Quarterly dividend raised to $0.15 per share from $0.10; record date November 20, 2026; payment December 4, 2026
Stockholders' equity fell to $78.45 million at September 30, 2026, as unrealized securities losses increased accumulated other comprehensive loss to $24.51 million
Pelthos Therapeutics agreed on October 30, 2026 to merge with Castle Creek Biosciences in a two-step merger, with Castle Creek becoming a wholly owned subsidiary. Castle Creek holders would receive 5,200,000 Pelthos shares at closing, plus contingent shares, milestone payments and priority review voucher proceeds, and would own about 32.5% of Pelthos on a fully diluted basis before the PIPE financing. Closing requires stockholder approvals from both companies and is expected by the end of the first quarter of 2027.
5,200,000 Pelthos common shares issued to Castle Creek holders at closing, about 32.5% of fully diluted shares before the PIPE financing
Up to 5,800,000 additional Pelthos shares if FDA approval of D-Fi is received on or before March 31, 2036
Up to $300 million in milestone payments tied to D-Fi clinical, commercial and net sales targets, plus 80% of any priority review voucher sale proceeds
Either party may terminate if the First Merger is not completed by February 1, 2027, subject to extension to March 31, 2027 in certain circumstances
Green Plains entered into a Tax Credit Purchase Agreement on October 29, 2026, to transfer Section 45Z clean fuel production tax credits from its 2026 ethanol production to two unaffiliated buyers. The deal covers a minimum of $250 million and up to $325 million in credits, and the company expects $140 million of cash in the fourth quarter for credits generated through June 30, 2026.
Minimum of $250 million and maximum of $325 million in 2026 Section 45Z credits, subject to generation and conditions
Company expects $140 million cash in Q4 2026 for credits generated through June 30, 2026
Credits from Q3 and Q4 2026 expected to be monetized in the first half of 2027
If a tax law change limits transferred credits, Green Plains must return the related purchase price with interest
Arbor Realty Trust reported a third-quarter 2026 GAAP net loss of $85.4 million, or $0.51 per diluted share, compared with net income of $38.5 million, or $0.20 per diluted share, a year earlier. Its Board suspended the quarterly common stock dividend effective immediately to preserve capital and maintain financial flexibility, which directly affects shareholder income.
Q3 2026 GAAP net loss of $85.4 million, or $(0.51) per diluted share, versus net income of $38.5 million, or $0.20, in Q3 2025
Distributable loss of $6.9 million, or $(0.04) per diluted share, versus distributable earnings of $72.9 million, or $0.35, a year earlier
Quarterly common stock dividend suspended effective immediately; dividends declared per common share were $0.17 in Q3 2026 versus $0.30 in Q3 2025
Net provision for credit losses of $53.0 million; non-performing loans rose to 32 with a UPB of $647.6 million from 19 with $428.8 million at June 30, 2026
IRADIMED reported third-quarter 2026 revenue of $24.2 million, up 14% from a year earlier, and GAAP diluted EPS of $0.51 versus $0.43. The company narrowed its full-year 2026 guidance, lowering the top end of its revenue and GAAP EPS ranges, which matters to shareholders because the outlook for the rest of the year is now less generous at the high end.
Q3 2026 revenue of $24.2 million, up from $21.2 million; net income of $6.5 million versus $5.6 million
Full-year 2026 revenue guidance changed to $91.6 million to $93.1 million from $91.0 million to $96.0 million
Full-year 2026 GAAP diluted EPS guidance changed to $1.90 to $1.94 from $1.90 to $2.05
Quarterly cash dividend of $0.20 per share, payable November 27, 2026 to holders of record on November 13, 2026
OpenWorld closed its merger with Blocksight Holdings Co. on October 27, 2026, and issued 641,924 common shares to the sellers, 275,110 of them subject to vesting restrictions. On October 29, 2026, the company agreed to a registered direct offering expected to raise about $3.5 million in gross proceeds before fees, with the offering expected to close on or about October 30, 2026; the new shares and warrants will add to the share count and may dilute existing shareholders.
Merger with Blocksight closed October 27, 2026; 641,924 shares issued to sellers, with 275,110 restricted and vesting monthly from the 22nd to 36th month after closing.
Registered direct offering of 1,494,084 common shares and 1,023,901 pre-funded warrants, with Series A and Series B warrants, priced at a combined $1.39 per share with warrants.
Gross proceeds expected to be about $3.5 million before placement agent fees and expenses; Patrick Kim named Blocksight CEO with a $250,000 annual base salary and $357,350 signing bonus.
Hilton Grand Vacations agreed on October 30, 2026 to repurchase $200 million of its common stock through an accelerated share repurchase with Deutsche Bank AG, London Branch. The company paid $200 million up front and received an initial delivery of approximately 4.48 million shares, with the final share count to be set at settlement based on volume-weighted average price, less a discount.
Company pays $200 million to the Dealer on October 30, 2026 and receives an initial delivery of approximately 4.48 million shares.
Final share count depends on the volume-weighted average price over the calculation period, less a discount; the Dealer may deliver additional shares at settlement.
Final settlement is expected no later than December 31, 2026, and the Dealer may accelerate the termination date on or after December 1, 2026.
Pluri Inc. entered into a partnership agreement with ZEO ScientifiX on October 26, 2026, under which ZEO would receive an exclusive US license to manufacture and commercialize Pluri's regenerative medicine products, with Pluri receiving equity in ZEO at closing. On October 27, 2026, Pluri agreed to sell 909,092 common shares and warrants to two investors for $1.0 million in total, with closing expected on or before October 30, 2026. The stock sale adds shares outstanding, and the ZEO transaction depends on closing conditions, including agreement on an operating plan.
October 26, 2026: ZEO partnership grants ZEO an exclusive US license to manufacture and commercialize Pluri's regenerative medicine products, excluding certain aesthetics, skin care, cosmetic, or veterinary uses, which ZEO may only commerci
At closing, Pluri is to receive 41% of ZEO's issued and outstanding shares plus 50 Series D Preferred shares carrying 51% of ZEO's votes
October 27, 2026: two Securities Purchase Agreements for 909,092 common shares at $1.10 per share, with warrants for an equal number of shares at $1.30 per share; closing expected on or before October 30, 2026
Aurinia reported third-quarter 2026 total revenue of $83.7 million, up 14% from a year earlier, while net income and diluted earnings per share were flat at $31.7 million and $0.23. The company raised its 2026 total revenue guidance to $325 million to $330 million and narrowed its net product sales guidance to $310 million to $315 million.
Q3 2026 total revenue was $83.7 million, up 14% from $73.5 million; net product sales of LUPKYNIS were $79.4 million.
Q3 net income was $31.7 million, flat year over year; nine-month net income rose 35% to $103.5 million.
2026 total revenue guidance raised from $315 million-$325 million to $325 million-$330 million.
As of September 30, 2026, cash, cash equivalents, restricted cash and investments totaled $486.9 million.
NextCure said its Chief Medical Officer, Dr. Udayan Guha, will be terminated effective October 31, 2026, in connection with the pending merger with Avere Therapeutics, Inc. He signed a severance agreement and release, and additional change-in-control severance is payable only if the merger closes.
Dr. Udayan Guha, Chief Medical Officer and a named executive officer, is terminated effective October 31, 2026.
The departure is tied to the pending merger of NextCure and Avere Therapeutics, Inc.
Severance follows his existing employment agreement; enhanced change-in-control severance applies only if the merger closes.
The filing does not state the dollar amount of severance.
Game Your Game Inc. (GYGY) received a Nasdaq notice that its stock has traded below the $1.00 minimum bid price for 30 consecutive business days, and it has until April 26, 2027 to regain compliance. The company's shares remain listed on the Nasdaq Capital Market for now, but failure to cure could lead to delisting proceedings.
Nasdaq letter dated October 27, 2026 cites closing bid below $1.00 over 30 business days ending October 26, 2026
Compliance period runs 180 calendar days to April 26, 2027; shares must close at or above $1.00 for 10 consecutive business days
Veronica V. Montenegro appointed to the board effective October 28, 2026, as governance committee chair and audit and compensation committee member
Director pay: $50,000 annual cash retainer, $27,500 additional cash for committee roles, and $77,500 in annual stock option grants
Colgate-Palmolive reported third quarter 2026 net sales of $5.37 billion, representing a 4.6% increase year over year, with GAAP earnings per share of $0.94. Driven by ongoing sales momentum and margin expansion, the company raised its full-year earnings per share growth guidance to 5% to 7% on a non-GAAP basis.
Net sales rose 4.6% to $5,369 million for the quarter ended September 30, 2026.
GAAP EPS increased 3% to $0.94, while Base Business EPS grew 7% to $0.97.
Full-year 2026 organic sales growth is now expected to be broadly in line with its nine-month performance.
Mammoth Energy Services reported third-quarter 2026 revenue of $21.3 million, up 95% from $10.9 million a year earlier, and net income from continuing operations of $0.3 million, or $0.01 per diluted share, compared with a $12.6 million loss in the same quarter of 2025. The company raised its full-year 2026 outlook for the third time this year and expects Adjusted EBITDA to grow by more than 40% in 2027, though third-quarter revenue fell from $26.1 million in the second quarter.
Q3 2026 revenue $21.3 million, up from $10.9 million in Q3 2025 but down from $26.1 million in Q2 2026
Adjusted EBITDA $5.8 million, compared with a loss of $4.8 million in Q3 2025 and $2.6 million in Q2 2026
Full-year 2026 outlook: revenue growth above 90% and Adjusted EBITDA margin in the mid-teens
2027 outlook: Adjusted EBITDA expected to rise more than 40% versus full-year 2026; subsequent to quarter-end, a term loan facility with Bank7 provides commitments of up to $58.0 million
AbbVie announced third-quarter 2026 net revenues of $17.404 billion and diluted EPS of $2.37 on a GAAP basis. The company raised its full-year 2026 adjusted diluted EPS guidance range to $13.95 through $13.99 and increased its quarterly cash dividend by 5.2 percent to $1.82 per share.
Third-quarter net revenues reached $17.404 billion, representing a 10.3 percent increase on a reported basis.
GAAP diluted EPS was $2.37, while adjusted diluted EPS was $3.82 for the third quarter ended September 30, 2026.
Full-year 2026 adjusted diluted EPS guidance was raised to a range of $13.95 to $13.99.
The quarterly cash dividend was increased by 5.2 percent to $1.82 per share, payable on February 16, 2027.
OmniAb reported third-quarter 2026 revenue of $4.0 million, up from $2.2 million a year earlier, and a net loss of $15.7 million, or $0.12 per share, narrowed from $16.5 million, or $0.14 per share. The company raised its full-year 2026 revenue guidance and its year-end cash outlook, which may matter to shareholders because the figures point to higher revenue and a smaller loss than in the prior-year period.
Q3 2026 revenue was $4.0 million versus $2.2 million in Q3 2025; net loss was $15.7 million, or $0.12 per share, versus $16.5 million, or $0.14 per share.
2026 revenue guidance is now $35 million to $39 million, up from $32 million to $36 million previously.
Year-end 2026 cash and cash equivalents outlook is $53 million to $57 million, up from $49 million to $53 million.
In Q3 2026, OmniAb entered a collaboration and license agreement with Eli Lilly and Company eligible for up to $370 million in milestone payments, plus royalties.
Gates Industrial reported third-quarter 2026 net sales of $903.6 million, up 5.6%, with diluted earnings per share of $0.34 versus $0.31 a year earlier and adjusted earnings per share of $0.47 versus $0.39. The company raised its full-year 2026 guidance for adjusted EBITDA and adjusted earnings per share, which benefits shareholders if the outlook is met.
Q3 net sales were $903.6 million, up 5.6%, with core sales up 5.5%.
Diluted EPS was $0.34 versus $0.31; adjusted EPS was $0.47 versus $0.39.
Adjusted EBITDA was $215.4 million, a 23.8% margin versus 22.9% a year earlier.
2026 adjusted EBITDA guidance is $809 million to $823 million (prior $800 million to $830 million); adjusted EPS guidance is $1.66 to $1.72 (prior $1.62 to $1.70).
LCI Industries' board unanimously determined that Monomoy Capital Partners' unsolicited, non-binding $101-per-share cash proposal is not a superior proposal and is not reasonably likely to lead to one. The board reiterated its support for the pending merger with Patrick Industries, which it expects to complete in the first half of 2027. Shareholders are asked to vote in favor of the Patrick merger at a special meeting scheduled for November 18, 2026.
Monomoy Capital Partners proposed $101 per share in cash for all LCI shares, announced October 28, 2026
LCI board says its standalone discounted cash flow value is in excess of $150 per share
Merger with Patrick expected to yield approximately $150 million in net run-rate cost synergies within three years of closing
Special shareholder meeting on the Patrick merger scheduled for November 18, 2026
Federal Realty Investment Trust reported third quarter 2026 net income available for common shareholders of $64.2 million, or $0.74 per diluted share, up from $59.6 million, or $0.69 per diluted share, in the prior-year period. The company raised and tightened its full-year 2026 Core FFO guidance to $7.54 to $7.58 per diluted share and announced the post-quarter acquisition of The Summit for $508.0 million.
Generated Nareit FFO and Core FFO of $1.87 per diluted share for the third quarter of 2026, representing a 5.6% increase year-over-year.
Signed 117 comparable retail leases totaling 532,220 square feet with cash rent growth of 14%.
Acquired The Summit in Birmingham, AL, for $508.0 million on October 1, 2026.
Raised full-year 2026 Core FFO guidance to a range of $7.54 to $7.58 per diluted share.
Cboe Global Markets reported third quarter 2026 net revenue of $712.2 million and diluted EPS of $4.08, driven by growth across its options, equities, and data businesses. Reflecting strong year-to-date performance, the company raised its full-year organic net revenue growth target and lowered its adjusted operating expense guidance.
Diluted EPS for the quarter reached $4.08, up 43 percent year over year.
Net revenue for the quarter rose 18 percent to $712.2 million.
Full-year 2026 organic total net revenue growth target was increased to high teens.
Adjusted operating expense guidance for 2026 was decreased to $830 to $845 million.
After Churchill Capital Corp XI's redemption deadline expired, Agility Robotics said its gross capital raise tied to the proposed business combination is expected to be about $465 million before transaction expenses. The business combination is expected to close on November 4, 2026, subject to Churchill XI shareholder approval, with the combined company expected to trade on Nasdaq under ticker AGLT from November 5, 2026. The filing gives no revenue or profit figures, and the final cash available to Agility depends on how many Churchill XI shareholders keep their redemption elections.
Gross capital raise expected to be about $465 million before transaction expenses, following the expiration of Churchill XI's redemption deadline.
Sources: about $164 million from the Churchill XI trust account, about $201 million from a common stock PIPE at $10 per share led by Foxconn, and $100 million of equity funding already received.
Churchill XI shareholder vote is scheduled at an extraordinary general meeting on November 2, 2026; closing is expected November 4 and Nasdaq trading November 5.
Churchill XI shareholders who asked to redeem their shares may withdraw that request at any time before the scheduled vote.
CubeSmart announced its third quarter 2026 operating results, reporting diluted earnings per share of $0.42 and adjusted funds from operations of $0.66 per diluted share. Driven by strong year-to-date performance, the company raised its full-year same-store and FFO guidance ranges for shareholders.
Diluted EPS attributable to common shareholders was $0.42 for the third quarter of 2026, compared to $0.36 in the third quarter of 2025.
Same-store net operating income increased 2.1% year over year to $172.6 million for the third quarter.
The company repurchased 2.1 million common shares for $83.9 million during the quarter at an average price of $39.09 per share.
Full-year diluted FFO per share, as adjusted, is now estimated to be between $2.58 and $2.60.
Lear reported third-quarter 2026 results with revenue of $5.8 billion, up 2%, and net income of $137 million, up 26%, with earnings per share of $2.74 versus $2.02 a year earlier. The company adjusted its full-year 2026 outlook for net sales to reflect changing production schedules, while maintaining its core operating earnings guidance of $1,080 million to $1,200 million.
Q3 2026 revenue of $5.8 billion, up 2% from $5.7 billion; net income of $137 million; EPS of $2.74 vs. $2.02
Core operating earnings of $256 million, up 6%; free cash flow of $158 million vs. $307 million a year earlier
2026 net sales outlook set at $23,350 million to $23,750 million; core operating earnings outlook maintained at $1,080 million to $1,200 million
Repurchased $175 million of shares in Q3; share repurchase authorization expanded to $1.5 billion, extended through December 31, 2029
Genworth Financial said President and CEO Thomas J. McInerney will retire and leave its board effective December 31, 2026. Jerome T. Upton, the company's CFO, will become President and CEO and join the board effective January 1, 2027, and Angela R. Simmons will become Executive Vice President and CFO on the same date.
Thomas J. McInerney retires as President and CEO and resigns from the board effective December 31, 2026.
Jerome T. Upton, currently CFO, is to become President and CEO and a board member effective January 1, 2027.
Angela R. Simmons, currently CFO of the Closed Block, is to become Executive Vice President and CFO effective January 1, 2027.
The filing says McInerney's retirement is not the result of any disagreement with the company, and compensation terms for Upton and Simmons will be disclosed later by amendment.
INVE Technologies revised its preliminary unaudited third-quarter 2026 results, first issued on October 21, 2026. Net income of $0.4 million to $0.8 million, or $0.01 to $0.02 per share, is now a net loss of $1.1 million to $1.3 million, or $0.05 to $0.06 per share, driven by post-closing adjustments tied to the asset sale to Trackonomy Systems, Inc. The expected cash balance of $87.1 million as of September 30, 2026 is unchanged, and the figures remain subject to quarter-end closing and auditor review.
Original preliminary net income of $0.4 million to $0.8 million, or $0.01 to $0.02 per share, reported October 21, 2026
Revised preliminary net loss of $1.1 million to $1.3 million, or $0.05 to $0.06 per share
Revisions reflect working capital adjustments and post-closing acceptance of certain customer contracts tied to the Trackonomy Systems, Inc. asset sale
Expected cash balance as of September 30, 2026 of $87.1 million remains unchanged
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.